Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Auteur de référence en rhumatologie
38 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (6 thèses dirigées)
Expérience confirmée
31 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
120.1 rhumatos / 100 000 hab. — département bien doté
31ans d'exercice (thèse 1995)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Méthodologies d'aide à la décision chez le patient traité par anticoagulant oral dans une maladie thrombo-embolique à partir d'études observationnelles
2024Doctorant·e : Yoann Gaboreau
Evaluation clinique d'une nouvelle technique incluant l'imagerie et la Chirurgie Assistée par Ordinateur pour éviter les greffes sinusiennes en chirurgie orale implantaire
2023Doctorant·e : Ghazwan Almahrous
Fiches d'Information pour les Patients (FIP), un outil au service de la communication médecin patient : Proposition et validation de méthodes pour la construction et l'évaluation clinique
2017Doctorant·e : Mélanie Sustersic
Structuration des connaissances en vue d'une évaluation de la qualité dans le domaine de la chirurgie augmentée
2013Doctorant·e : Jean-Jacques Banihachémi
Réactualisation de modèles épidémiologiques et application à la maladie thromboembolique veineuse
2010Doctorant·e : Marie-antoinette Sevestre
Réactualisation de modèles épidémiologiques et application à la maladie thromboembolique veineuse
2010Doctorant·e : Marie-Antoinette Sevestre-Pietri
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
No association between carbohydrate-counting knowledge and disordered eating behaviors in adults with type 1 diabetes
2026ArticleDiabetes & Metabolism
Transcranial Doppler to guide early discharge after mild traumatic brain injury, the TRUST trial: study protocol for an open-label multisite noninferiority randomized controlled trial
2025ArticleTrials
ODIASP: An Open‐Source Software for Automated SMI Determination—Application to an Inpatient Population
2025ArticleJournal of Cachexia, Sarcopenia and Muscle
Treatment of isolated distal deep vein thrombosis: an international survey of healthcare professionals
2025ArticleJournal of Thrombosis and Thrombolysis
Assessing Real-Life Food Consumption in Hospital with an Automatic Image Recognition Device: a pilot study
2025ArticleClinical Nutrition ESPEN
Construction d’une méthodologie d’évaluation clinique des dispositifs médicaux grâce aux outils de simulation et illustration à travers trois études
2025ArticleAnnales Pharmaceutiques Françaises
Millimetre wave-based neuromodulation combined with coaching improves quality of life in fibromyalgia patients: A 9-month prospective, multicenter, open, randomized, controlled trial
2025ArticleMedicine
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia
2025ArticleAmerican Heart Journal
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
HOPITAL NORD - CHU38
BD DE LA CHANTOURNE, 38700 LA TRONCHE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
JAMA · 2023
ImportanceOptimal transfusion strategies in traumatic hemorrhage are unknown. Reports suggest a beneficial effect of 4-factor prothrombin complex concentrate (4F-PCC) on blood product consumption.ObjectiveTo investigate the efficacy and safety of 4F-PCC administration in patients at risk of massive transfusion.Design, Setting, and ParticipantsDouble-blind, randomized, placebo-controlled superiority trial in 12 French designated level I trauma centers from December 29, 2017, to August 31, 2021, involving consecutive patients with trauma at risk of massive transfusion. Follow-up was completed on August 31, 2021.InterventionsIntravenous administration of 1 mL/kg of 4F-PCC (25 IU of factor IX/kg) vs 1 mL/kg of saline solution (placebo). Patients, investigators, and data analysts were blinded to treatment assignment. All patients received early ratio-based transfusion (packed red blood cells:fresh frozen plasma ratio of 1:1 to 2:1) and were treated according to European traumatic hemorrhage guidelines.Main Outcomes and MeasuresThe primary outcome was 24-hour all blood product consumption (efficacy); arterial or venous thromboembolic events were a secondary outcome (safety).ResultsOf 4313 patients with the highest trauma level activation, 350 were eligible for emergency inclusion, 327 were randomized, and 324 were analyzed (164 in the 4F-PCC group and 160 in the placebo group). The median (IQR) age of participants was 39 (27-56) years, Injury Severity Score was 36 (26-50 [major trauma]), and admission blood lactate level was 4.6 (2.8-7.4) mmol/L; prehospital arterial systolic blood pressure was less than 90 mm Hg in 179 of 324 patients (59%), 233 patients (73%) were men, and 226 (69%) required expedient hemorrhage control. There was no statistically or clinically significant between-group difference in median (IQR) total 24-hour blood product consumption (12 [5-19] U in the 4F-PCC group vs 11 [6-19] U in the placebo group; absolute difference, 0.2 U [95% CI, −2.99 to 3.33]; P = .72). In the 4F-PCC group, 56 patients (35%) presented with at least 1 thromboembolic event vs 37 patients (24%) in the placebo group (absolute difference, 11% [95% CI, 1%-21%]; relative risk, 1.48 [95% CI, 1.04-2.10]; P = .03).Conclusions and RelevanceAmong patients with trauma at risk of massive transfusion, there was no significant reduction of 24-hour blood product consumption after administration of 4F-PCC, but thromboembolic events were more common. These findings do not support systematic use of 4F-PCC in patients at risk of massive transfusion.Trial RegistrationClinicalTrials.gov Identifier: NCT03218722
The Lancet. Neurology · 2023
International journal of medical informatics · 2023
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Rheumatology (Oxford, England) · 2026 · Journal Article
Maindet C, Giai J, Leroy C, Proust M, et al.
Antimicrobial resistance and infection control · 2025 · Journal Article
Gallouche M, Rubens-Duval B, Boisset S, Margotton M, et al.
Trials · 2025 · Journal Article
Bouzat P, Gauss T, Adolle A, Roustit M, et al.
European journal of anaesthesiology · 2025 · Journal Article
Bruillot M, Pieper A, Sourd D, Roge A, et al.
Medicine · 2025 · Journal Article
Maindet C, Minier L, Chipon E, Véloso M, et al.
American heart journal · 2025 · Clinical Trial Protocol
Barone-Rochette G, Vanzetto G, Danchin N, Steg PG, et al.
Journal of clinical medicine · 2024 · Journal Article
Gaboreau Y, Milovančev A, Rolland C, Eychenne C, et al.
The Lancet. Neurology · 2023 · Randomized Controlled Trial
Payen JF, Launey Y, Chabanne R, Gay S, et al.
Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023 · Randomized Controlled Trial
Moury PH, Pasquier V, Greco F, Arvieux JL, et al.
JAMA · 2023 · Journal Article
Bouzat P, Charbit J, Abback PS, Huet-Garrigue D, et al.
BMC geriatrics · 2023 · Published Erratum
Gavazzi G, Drevet S, Debray M, Bosson JL, et al.
BMC geriatrics · 2022 · Randomized Controlled Trial
Gavazzi G, Drevet S, Debray M, Bosson JL, et al.
The Lancet. Haematology · 2022 · Randomized Controlled Trial
Galanaud JP, Genty-Vermorel C, Barrellier MT, Becker F, et al.
Trials · 2022 · Clinical Trial Protocol
Chipon E, Bosson JL, Minier L, Dumolard A, et al.
Studies in health technology and informatics · 2026 · Journal Article
Beaudoin PA, Cance C, Achard S, Bosson JL, et al.
Research and practice in thrombosis and haemostasis · 2026 · Journal Article
Galanaud JP, Genty-Vermorel C, Terriat B, Stansal A, et al.
Medical engineering & physics · 2025 · Journal Article
Poiron V, Letout S, Gumery PY, Nougier V, et al.
Clinical nutrition ESPEN · 2025 · Journal Article
Albaladejo L, Giai J, Deronne C, Baude R, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Maindet C, Giai J, Leroy C, Proust M, et al.
Family practice · 2024 · Journal Article
Gaboreau Y, Frappé P, Vermorel C, Foote A, et al.
JAMA · 2023 · Journal Article
Bouzat P, Charbit J, Abback PS, Huet-Garrigue D, et al.
BMJ open · 2023 · Review
Artemova S, von Schenck U, Fa R, Stoessel D, et al.
International journal of medical informatics · 2023 · Systematic Review
Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, et al.
Medicine · 2025 · Journal Article
Maindet C, Minier L, Chipon E, Véloso M, et al.
Trials · 2022 · Clinical Trial Protocol
Chipon E, Bosson JL, Minier L, Dumolard A, et al.
EClinicalMedicine · 2023 · Journal Article
van Hylckama Vlieg MAM, Nasserinejad K, Visser C, Bramer WM, et al.
Journal of medical Internet research · 2023 · Systematic Review
Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, et al.
EClinicalMedicine · 2023 · Journal Article
van Hylckama Vlieg MAM, Nasserinejad K, Visser C, Bramer WM, et al.
Journal of medical Internet research · 2023 · Systematic Review
Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, et al.
Preventive medicine reports · 2023 · Journal Article
Lynch AM, Kilroy S, McKee H, Sheerin F, et al.
International journal of clinical pharmacy · 2025 · Journal Article
Clarenne J, Mongaret C, Vermorel C, Bosson JL, et al.
Thrombosis research · 2022 · Journal Article
Godon A, Gabin M, Levy JH, Huet O, et al.
American heart journal · 2025 · Clinical Trial Protocol
Barone-Rochette G, Vanzetto G, Danchin N, Steg PG, et al.
Pediatric blood & cancer · 2024 · Journal Article
Magnier O, Schiff I, Cristante J, Chabre O, et al.
The American journal of cardiology · 2023 · Journal Article
Larsson CE, Cabassut V, Peretout P, Marliere S, et al.
Trials · 2022 · Clinical Trial Protocol
Chipon E, Bosson JL, Minier L, Dumolard A, et al.
Clinical impact of the disposable ventouse iCup® versus a metallic vacuum cup: a multicenter randomized controlled trial
Abstract Background Assisted vaginal delivery by vacuum extraction is frequent. Metallic resterilizible metallic vacuum cups have been routinely used in France. In the last few years a new disposable semi-soft vacuum ext
Diaphragm thickening in cardiac surgery: a perioperative prospective ultrasound study
Abstract Background Diaphragm paresis is common after cardiac surgery and may delay the weaning from the ventilator. Our objective was to evaluate diaphragm thickening during weaning and secondly the muscle thickness as
MOESM3 of Diaphragm thickening in cardiac surgery: a perioperative prospective ultrasound study
Additional file 3. Comparisons of right hemi-diaphragm thickness assessed independently by two different raters during a spontaneous breathing trial.
A drug free solution for improving the quality of life of fibromyalgia patients (Fibrepik): study protocol of a multicenter, randomized, controlled effectiveness trial
Abstract Background Fibromyalgia is a form of chronic widespread pain that is defined as a syndrome of chronic symptoms of moderate to severe intensity, including diffuse pain, fatigue, sleep disturbance, cognitive impai
Early prediction of in-hospital mortality utilizing multivariate predictive modelling of electronic medical records and socio-determinants of health of the first day of hospitalization
Abstract Background In France an average of 4% of hospitalized patients die during their hospital stay. To aid medical decision making and the attribution of resources, within a few days of admission the identification o
Clinical impact of the disposable ventouse iCup® versus a metallic vacuum cup: a multicenter randomized controlled trial
Abstract Background Assisted vaginal delivery by vacuum extraction is frequent. Metallic resterilizible metallic vacuum cups have been routinely used in France. In the last few years a new disposable semi-soft vacuum ext
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Journal of thrombosis and thrombolysis · 2025 · Journal Article
Makedonov I, Kapitanski L, Giai J, Vermorel C, et al.
Journal of neurotrauma · 2025 · Journal Article
Payen JF, Vilotitch A, Gauss T, Adolle A, et al.
Annales pharmaceutiques francaises · 2025 · English Abstract
Salomez-Ihl C, Chapuis C, Albaladejo P, Picard M, et al.
Family practice · 2024 · Journal Article
Gaboreau Y, Frappé P, Vermorel C, Foote A, et al.
Journal of thrombosis and haemostasis : JTH · 2024 · Journal Article
Galanaud JP, Krebs-Drouot L, Genty-Vermorel C, Geerts W, et al.
Antimicrobial resistance and infection control · 2024 · Journal Article
Portais A, Gallouche M, Pavese P, Caspar Y, et al.
BMC medical informatics and decision making · 2023 · Journal Article
Stoessel D, Fa R, Artemova S, von Schenck U, et al.
Medical physics · 2023 · Journal Article
Charrière K, Boulouard Q, Artemova S, Vilotitch A, et al.
Infectious diseases now · 2023 · Journal Article
Gallouche M, Landelle C, Larrat S, Truffot A, et al.
Medical engineering & physics · 2022 · Published Erratum
Barth SR, Pinsault N, Terrisse H, Eychenne C, et al.